13F-HR filed by Ikarian Capital, LLC
Ikarian Capital, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 86 holding rows worth $414,502,576.
- Accession
- 0001420506-23-000695
- Filer
- CIK 1778253
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 86 entries on the cover page, a total value of $414,502,576 stated on the cover page (in dollars after the unit check, H1), rows summing to $414,502,576 with VALUE read as dollars as filed, 13F file number 028-19721. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 300,000 | $87,075,000 | dollars as filed | put |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 288,926 | $31,781,860 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 966,700 | $17,158,925 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 165,900 | $13,142,598 | dollars as filed | put |
| VAXCYTE INC COM | 92243G108 | Stock | 250,000 | $11,987,501 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 267,476 | $11,921,406 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,891,147 | $11,781,846 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 837,500 | $11,624,500 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 100,000 | $11,000,000 | dollars as filed | call |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 89,219 | $10,153,123 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 675,176 | $10,053,370 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 577,400 | $9,498,230 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $8,300,000 | dollars as filed | put |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $8,300,000 | dollars as filed | call |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,296,900 | $8,079,687 | dollars as filed | call |
| IVERIC BIO INC | 46583P102 | COM | 377,021 | $8,072,019 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 201,200 | $7,643,588 | dollars as filed | put |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 737,319 | $7,505,908 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 885,334 | $7,277,445 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 255,131 | $6,666,573 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 160,486 | $6,327,963 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 367,119 | $6,017,081 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 283,100 | $5,854,508 | dollars as filed | put |
| 89BIO INC | 282559103 | COM | 454,000 | $5,779,419 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 812,628 | $5,623,385 | dollars as filed | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 250,000 | $5,370,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 200,000 | $5,226,000 | dollars as filed | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 325,000 | $5,174,001 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 108,100 | $4,898,010 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 273,432 | $4,497,956 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 629,986 | $4,435,102 | dollars as filed | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 2,765,530 | $4,120,639 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 1,378,825 | $3,929,651 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 127,921 | $3,748,085 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 28,324 | $3,670,224 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 100,000 | $3,421,000 | dollars as filed | call |
| SEAGEN INC | 81181C104 | COM | 25,000 | $3,212,750 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 137,987 | $2,853,572 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 67,805 | $2,586,083 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 171,100 | $2,547,679 | dollars as filed | call |
| MERUS N V | N5749R100 | COM | 156,000 | $2,413,320 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 203,156 | $1,909,666 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 460,416 | $1,823,248 | dollars as filed | |
| GERON CORP | 374163103 | COM | 650,000 | $1,573,000 | dollars as filed | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 422,625 | $1,563,713 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 254,945 | $1,376,703 | dollars as filed | |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 46,462 | $1,311,622 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 343,685 | $1,079,171 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 85,200 | $1,053,924 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 139,565 | $1,017,429 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 313,392 | $1,002,855 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 650,000 | $910,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 62,766 | $725,576 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 200,000 | $562,000 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 221,830 | $514,645 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 188,664 | $505,619 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 1,800 | $498,456 | dollars as filed | call |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 48,500 | $497,610 | dollars as filed | put |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 260,087 | $494,166 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 26,200 | $465,050 | dollars as filed | call |
| IMMATICS N.V | N44445109 | SHS | 49,031 | $427,060 | dollars as filed | |
| ANEBULO PHARMACEUTICALS INC | 034569103 | COM | 156,203 | $374,888 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 155,819 | $363,059 | dollars as filed | |
| GERON CORP | 374163103 | COM | 150,000 | $363,000 | dollars as filed | put |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 150,000 | $357,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 349,133 | $346,689 | dollars as filed | |
| BELLICUM PHARMACEUTICALS INC COM NEW | 079481404 | Stock | 448,101 | $322,633 | dollars as filed | |
| BRAINSTORM CELL THERAPEUTICS | 10501E201 | COM | 189,935 | $311,494 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 30,286 | $280,145 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 962 | $266,398 | dollars as filed | |
| SYNLOGIC INC | 87166L100 | COM | 306,757 | $233,135 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 65,491 | $228,563 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 219,501 | $190,482 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 820,455 | $151,446 | dollars as filed | |
| ARK ETF TR | 00214Q104 | INNOVATION ETF | 4,519 | $141,174 | dollars as filed | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 136,059 | $122,453 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 11,568 | $118,689 | dollars as filed | |
| FINCH THERAPEUTICS GROUP INC | 31773D101 | COM | 237,553 | $114,026 | dollars as filed | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 176,980 | $65,217 | dollars as filed | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 397,168 | $43,888 | dollars as filed | |
| TRICIDA INC | 89610F101 | COM | 145,700 | $22,277 | dollars as filed | call |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 75 | $21,770 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,100 | $13,237 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 800 | $8,208 | dollars as filed | call |
| PHAXIAM THERAPEUTICS S A | 29604W108 | SPONSORED ADR | 3,019 | $1,185 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 283,464 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000695 | this filing | 2023-02-14 | acceptance time not in the bulk data set |